Targeting non-coding RNA H19: A potential therapeutic approach in pulmonary diseases
Non-coding RNA is still one of the most popular fields in biology research. In recent years, people paid more attention to the roles of H19 in lung diseases, which expressed abnormally in various pathological process. Therefore, this review focus on the regulatory role of H19 in asthma, pulmonary ar...
Main Authors: | Jinghui Xie, Yuedi Hu, Dengdi Sun, Changan Liu, Zegeng Li, Jie Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.978151/full |
Similar Items
-
Long non coding RNA H19: An emerging therapeutic target in fibrosing diseases
by: Juan Li, et al.
Published: (2020-01-01) -
Non-Coding RNA in Cholangiocarcinoma: An Update
by: Jiehan Li, et al.
Published: (2023-08-01) -
Integration of metabolomics and network pharmacology to reveal the protective mechanism underlying Qibai Pingfei capsule on chronic obstructive pulmonary disease
by: Jinghui Xie, et al.
Published: (2023-10-01) -
Research progress on subcellular localization and function of long non-coding RNA
by: SU Yue, LIANG Linhui, HE Xianghuo
Published: (2023-10-01) -
Mutual Correlation between Non-Coding RNA and S-Adenosylmethionine in Human Cancer: Roles and Therapeutic Opportunities
by: Laura Mosca, et al.
Published: (2021-06-01)